Radiotherapy for AMD
Renewed interest in the efficacy of radiation therapy for neovascular AMD has prompted the initiation of large randomized clinical trials for epimacular brachytherapy. In the past, trials for external beam techniques did not produce definitive results. This new technique provides more specific targeting of radiation to specific damaged areas with less collateral damage. Epimacular brachytherapy has shown promising results in two pilot studies, the CABERNET trial taking place in 45 sites in the US, and the MERLOT trial in the United Kingdom.










PRINT

Comments
Post new comment